These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 21282539)
1. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539 [TBL] [Abstract][Full Text] [Related]
2. Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up. Mead GM; Fossa SD; Oliver RT; Joffe JK; Huddart RA; Roberts JT; Pollock P; Gabe R; Stenning SP; J Natl Cancer Inst; 2011 Feb; 103(3):241-9. PubMed ID: 21212385 [TBL] [Abstract][Full Text] [Related]
3. Carboplatin in clinical stage I seminoma: too much and too little at the same time. Bosl GJ; Patil S J Clin Oncol; 2011 Mar; 29(8):949-52. PubMed ID: 21282532 [No Abstract] [Full Text] [Related]
4. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP; Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331 [TBL] [Abstract][Full Text] [Related]
5. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature. Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941 [TBL] [Abstract][Full Text] [Related]
6. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature. Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942 [TBL] [Abstract][Full Text] [Related]
7. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience. Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797 [TBL] [Abstract][Full Text] [Related]
8. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200 [TBL] [Abstract][Full Text] [Related]
9. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma. Dieckmann KP; Matthies C; Kliesch S J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458 [No Abstract] [Full Text] [Related]
10. [Radiotherapy in stage I testicular seminoma: retrospective study and review of literature]. Bauduceau O; Souleau B; Le-Moulec S; Houlgatte A; Bernard O Cancer Radiother; 2003 Dec; 7(6):386-94. PubMed ID: 14725912 [TBL] [Abstract][Full Text] [Related]
11. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A; J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698 [TBL] [Abstract][Full Text] [Related]
12. The sword of Damocles and the treatment of stage I seminoma. Oliver T; Mead G; Mason M; Stenning S; Dieckmann K; Steiner H; De Santis M; Aparicio J; Skoneczna I; Kratzik C J Clin Oncol; 2006 Jun; 24(16):2599-600. PubMed ID: 16735720 [No Abstract] [Full Text] [Related]
13. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012. Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant carboplatin treatment for seminoma clinical stage I. Dieckmann KP; Krain J; Küster J; Brüggeboes B J Cancer Res Clin Oncol; 1996; 122(1):63-6. PubMed ID: 8543595 [TBL] [Abstract][Full Text] [Related]
15. Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events. Chandran EA; Chindewere A; North R; Jameson MB Cancer Rep (Hoboken); 2021 Apr; 4(2):e1310. PubMed ID: 33103860 [TBL] [Abstract][Full Text] [Related]
16. Treatment of stage I seminoma: is it time to change your practice? Feldman DR; Bosl GJ J Hematol Oncol; 2008 Nov; 1():22. PubMed ID: 18992162 [TBL] [Abstract][Full Text] [Related]
17. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP; Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556 [TBL] [Abstract][Full Text] [Related]
18. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma. Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin. Yathiraj PH; Sharan K; Fernandes DJ; Vidyasagar MS J Cancer Res Ther; 2016; 12(4):1216-1219. PubMed ID: 28169230 [TBL] [Abstract][Full Text] [Related]
20. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]